| ²é¿´: 1566 | »Ø¸´: 6 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
Îҵı³°ü
|
[ÇóÖú]
ÇóÖúÁòËáÌØ²¼ËûÁÖµÄרÀûµ½ÆÚÈÕ£¬ÒªÖйúºÍÃÀ¹úµÄ£¬×îºÃ½«·½·¨ÒÔ´«ÊÚһϣ¡Ð»Ð»£¡
|
|
| §Ý§Ý§Ý§Ý§Ý§Ý§Ý§Ý§Ý§Ý |
» ²ÂÄãϲ»¶
26¿¼²©ÉêÇë ѧorר
ÒѾÓÐ15È˻ظ´
È˹¤ÖÇÄܸ³ÄܾۺÏÎï¼°¸´ºÏ²ÄÁÏÄ£ÐÍÓ¦ÓÃÓëʵ¼ù
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ291È˻ظ´
¸÷¹úºÍ¹ú¼Ê×éÖ¯ÏÖÐÐÒ©µä×¢ÉäÓÃË®ÖÊÁ¿±ê×¼
ÒѾÓÐ0È˻ظ´
ÇóÖúÓÃ΢Æ×Êý¾Ý¿â²éѯ
ÒѾÓÐ0È˻ظ´
¼ÆË㻯ѧÓëÈ˹¤ÖÇÄÜÇý¶¯µÄMOFsÐÔÄÜÔ¤²âÓëɸѡ¼¼Êõ
ÒѾÓÐ0È˻ظ´
ÑÐÈýʵÑéÇóÖ¸µ¼
ÒѾÓÐ0È˻ظ´
½ðÊô²ÄÁ϶à³ß¶È¼ÆËãÄ£Äâ¼¼ÊõÓëÓ¦ÓãºÎ¢¹Û»úÀíµ½ºê¹ÛÐÔÄܵɹ¤×÷
ÒѾÓÐ0È˻ظ´
½Î÷¿Æ¼¼Ê¦·¶´óѧ΢ÉúÎïÌìȻҩÎïÀÏʦ½éÉÜ
ÒѾÓÐ23È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
äåÒÒÏ©µÄsonagashira·´Ó¦ÇóÖú
ÒѾÓÐ16È˻ظ´
´¿ÐÂÊÖ£¬È«·½ÃæÇóÖú¹ØÓÚMATLAB........
ÒѾÓÐ9È˻ظ´
Ó¢ÃÀÎÄѧ˶ʿ¿¼²©ÇóÖú~
ÒѾÓÐ45È˻ظ´
ÇóÖúÒºÏà·½·¨ÏßÐÔ¿¼²éÎÊÌ⣡¼±£¡£¡£¡£¡
ÒѾÓÐ27È˻ظ´
ÇóÖú·Òë
ÒѾÓÐ4È˻ظ´
(ÇóÖú)ÈçºÎÌáȡϸ¾ú±íÃæµÄĤµ°°×
ÒѾÓÐ3È˻ظ´
µ¥»ú¶àºËÒ»¸öcpuµÄ´®Ðв¢ÐÐÇóÖú
ÒѾÓÐ26È˻ظ´
ÇóÖú£º¹ØÓÚXPS,PtÔØÔÚITO²£Á§ÉϵÄXPSͼÆ×Öв»Ã÷µÄ·åΪºÎÎï
ÒѾÓÐ3È˻ظ´
ÇóÖú£º¹ØÓÚÔËË㸴ÔӶȵļÆË㣬лл´ó¼ÒÁË£¡
ÒѾÓÐ3È˻ظ´
ÇóÖú£ºÓйØÄÜË¹ÌØ·½³ÌµÄ˼¿¼£¡
ÒѾÓÐ4È˻ظ´
ÓÃõ£ÂÈÀ´·â¾Ûõ¥·Ö×ÓÁ´ÉϵÄôÇ»ù£¬ÇóÖú
ÒѾÓÐ7È˻ظ´
ÇóÖú-¹ØÓÚÏã¸ÛÀí¹¤»úе¹¤³Ìϵ¶Á²©
ÒѾÓÐ4È˻ظ´
¾ÛÒÒÏ©ÃÉÍÑÍÁDSCÇóÖú
ÒѾÓÐ7È˻ظ´
ÇóÖú»¤·ôÆ·Åä·½
ÒѾÓÐ17È˻ظ´
ÇóÖú ÃÀ¹ú¹«Ë¾¼°ÆäËû¹ú¼Ò£¨°üÀ¨Öйú£¬Íâ¹ú£©µÄרÀû
ÒѾÓÐ9È˻ظ´
Îҵı³°ü
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 76.9
- Ìû×Ó: 42
- ÔÚÏß: 3.2Сʱ
- ³æºÅ: 1180617
- ×¢²á: 2010-12-30
- רҵ: Ò©Îﻯѧ
5Â¥2012-06-08 15:04:06
xbqewpq
ÈÙÓþ°æÖ÷ (ÖøÃûдÊÖ)
»êÙâ
- DRDEPI: 1
- Ó¦Öú: 483 (˶ʿ)
- ¹ó±ö: 1.827
- ½ð±Ò: 8677.9
- É¢½ð: 2014
- ºì»¨: 36
- ɳ·¢: 14
- Ìû×Ó: 2144
- ÔÚÏß: 533.9Сʱ
- ³æºÅ: 1820818
- ×¢²á: 2012-05-16
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
- ¹ÜϽ: ·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
½ø¿ÚÒ©Æ·Óе½ÆÚʱ¼ä£¬¹úÄÚµÄÒ©Æ·¾ÍûÓÐÁË¡£ http://www.drugfuture.com/cndrug ... aFieldSelected=auto |

2Â¥2012-06-01 21:24:46
Îҵı³°ü
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 76.9
- Ìû×Ó: 42
- ÔÚÏß: 3.2Сʱ
- ³æºÅ: 1180617
- ×¢²á: 2010-12-30
- רҵ: Ò©Îﻯѧ
3Â¥2012-06-05 16:34:56
zhenyu19
ľ³æ (СÓÐÃûÆø)
à½à½
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2191.6
- ºì»¨: 4
- Ìû×Ó: 151
- ÔÚÏß: 50.2Сʱ
- ³æºÅ: 546989
- ×¢²á: 2008-04-16
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
Ò©Æ·Ãû³Æ BRICANYL ÉêÇëºÅ 017466 ²úÆ·ºÅ 001 »îÐÔ³É·Ö TERBUTALINE SULFATE Êг¡×´Ì¬: Í£Ö¹ÉÏÊÐ ¼ÁÐÍ»ò¸øÒ©Í¾¾¶ INJECTABLE; INJECTION ¹æ¸ñ 1MG/ML ÖÎÁƵÈЧ´úÂë ²Î±ÈÒ©Îï ·ñ Åú×¼ÈÕÆÚ Approved Prior to Jan 1, 1982 ÉêÇë»ú¹¹ SANOFI AVENTIS US LLC »¯Ñ§ÀàÐÍ New molecular entity (NME) ÉóÆÀ·ÖÀà Priority review drug ÊÇÕâ¸öÆ·ÖÖÂ𣿳¬ÀϵÄÒ©°¡£¬»¹ÓÐרÀû£¿ |
4Â¥2012-06-06 10:11:55














»Ø¸´´ËÂ¥